Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Foals with Rhodococcus equi infection often have other health problems that lower their chances of survival.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Finasteride may cause slight depression and anxiety.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.